Effectiveness of the RemedRugby Program (RemedRugby)

March 14, 2019 updated by: Dr Julien Dubreucq, Hospital Center Alpes-Isère

Effectiveness of the RemedRugby Program, a Program of Ecological Cognitive Remediation of Social Cognition Disorders in Schizophrenia

REMEDRUGBY's objective is to strengthen the capacity of users to interact with others in an assertive way and to fight against stigma. It proposes to specifically target the processes of "social cognition".

"Social cognition" brings together the mental mechanisms that allow everyone to decipher the social situations, emotions and intentions of others and interact with others in the different contexts of everyday life.

People with a psychic handicap frequently have difficulties in this area, which has often important consequences for their social and professional integration.

The REMEDRUGBY program proposes to work specifically on these processes in the context of sport (+ role Play and blog) to strengthen the ability to interact with others and to deal with the stigma that can be encountered on a daily basis.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Aura
      • Annecy, Aura, France, 74000
        • CH Annecy-Genevois
      • Bron, Aura, France, 69678
        • CH Le Vinatier
      • Chambéry, Aura, France, 73000
        • CHS de la Savoie
      • Clermont-Ferrand, Aura, France, 63000
        • Ch Sainte-Marie
      • Clermont-Ferrand, Aura, France, 63000
        • CHU de Clermont-Ferrand
      • Saint-Égrève, Aura, France, 38120
        • HCAlpesIsere
      • Saint-Étienne, Aura, France, 42000
        • CHU Saint-Etienne
      • Valence, Aura, France, 26000
        • Chs Le Valmont

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of schizophrenia, schizo-affective disorder (DSM-V criteria; APA, 2013).
  • French mother tongue.
  • psychotropic treatment unchanged during the month prior to inclusion.
  • Patients who gave their informed consent to participate in the study.
  • affiliated with a social security scheme or beneficiary of such a scheme
  • Subject suitable for the practice of sport.

Exclusion Criteria:

  • Recent dependence and abuse on cannabis or any other substance (DSM-V criteria), except tobacco.
  • Neurological disorders of vascular, infectious or neurodegenerative origin.
  • taking of medicinal products with a cerebral or psychic impact (e.g., corticosteroids).
  • Inability to practice sport
  • Pregnancy planned or in progress
  • Simultaneous Participation in any other program of remediation of social cognition, training in social skills, self-esteem.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: REMEDRUGBY
TAU + RemedRugby Program
  • 1st Session presentation of the programme, its objectives and a common reflection on the concepts of stigmatization/destigmatization.
  • 2nd to 4th session devoted to a group reflection on social conventions and their meaning followed by a practice by means of role-playing.
  • 5th to 7th session devoted to writing comments about tournaments on the blog by working on the intentions of others and the emotional impact of comments on their recipients.
  • 8th, 9th 11th sessions devoted to media relations with group reflection on the image of themselves and their pathology that participants wish to refer to the media, followed by a practice in role-playing games Interviewer-interviewed
  • 10th session devoted to planning and organizing the day of matches with writing a program of the day and spreading on the blog
  • 12th General Debriefing session Including : - 3 tournaments
  • 8 hours of Touch Rugby
Treatment as usual
Active Comparator: TAU + TOUCH RUGBY
TAU + Touch Rugby Program
Treatment as usual
Practical training Program at Touchrugby at the rate of 12 weekly sessions of 2 hours and 3 inter-institutional tournaments per day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movie to Assess Social Cognition (MASC)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
Changes in the aggregates (average) of standardized performance levels : z-scores of Theory of Mind (range 0-45) during social cognitive remediation
Changes between baseline function, after intervention and at 6 months of follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive and Negative Symptoms Scale for Schizophrenia (PANSS)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
Changes in the aggregates (average) of standardized performance levels : z-scores of positive and negative symptoms (minimum score 30- maximum score 210) of schizophrenia after social cognitive remediation
Changes between baseline function, after intervention and at 6 months of follow-up
Personal and Social Performance scale (PSP)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
Changes in the aggregates (average) of standardized performance levels : z-scores of social function (0 to 100) after social cognitive remediation
Changes between baseline function, after intervention and at 6 months of follow-up
Self Esteem Rating Scale (SERS)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
Changes in the aggregates (average) of standardized performance levels : z-scores (minimum score 10-maximum score 70) in self-assessment of self-esteem
Changes between baseline function, after intervention and at 6 months of follow-up
Boston University Empowerment Scale (BUES)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
Changes in the aggregates (average) of standardized performance levels : z-scores (minimum score 1- maximum score 4) in self-assessment of empowerment
Changes between baseline function, after intervention and at 6 months of follow-up
Internalized Stigma of Mental Illness (ISMI)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
self-assessment of internalized stigma
Changes between baseline function, after intervention and at 6 months of follow-up
Stages of Recovery Instrument (STORI)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
Self-assessment of personal recovery
Changes between baseline function, after intervention and at 6 months of follow-up
Social Perception and Knowledge (PerSo)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
cognitive task to assess competence in perception of social situations and social knowledge
Changes between baseline function, after intervention and at 6 months of follow-up
Ambiguous Intentions and Hostility Questionnaire (AIHQ)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
Changes in the aggregates (average) of standardized performance levels : z-scores (minimum score 1, maximum score 6) at a cognitive task to measure hostile social cognitive bias
Changes between baseline function, after intervention and at 6 months of follow-up
Questionnaire of Cognitive and Affective Empathy
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
Changes in the aggregates (average) of standardized performance levels : z-scores (minimum score 31, maximum score 124) in a self-assessment of empathy
Changes between baseline function, after intervention and at 6 months of follow-up
French National Adult Reading Test (f-NART
Time Frame: Baseline measure only
cognitive task to assess premorbid intellectual quotient (IQ)
Baseline measure only
Trail Making Test A (TMT A)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
cognitive task to assess speed of processing
Changes between baseline function, after intervention and at 6 months of follow-up
Trail Making Test B (TMT B)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
cognitive task to assess reactive mental flexibility
Changes between baseline function, after intervention and at 6 months of follow-up
Self-assessment of Social Cognition (AcSo)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
self-assessment of patient' perception of social cognitive deficits
Changes between baseline function, after intervention and at 6 months of follow-up
Commission Test (modified zoo test)
Time Frame: Changes between baseline function, after intervention and at 6 months of follow-up
cognitive task to asess planification abilities
Changes between baseline function, after intervention and at 6 months of follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2014

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

July 27, 2018

First Submitted That Met QC Criteria

December 11, 2018

First Posted (Actual)

December 14, 2018

Study Record Updates

Last Update Posted (Actual)

March 15, 2019

Last Update Submitted That Met QC Criteria

March 14, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2014-A01612-45

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on REMEDRUGBY PROGRAM

3
Subscribe